SEP 08, 2020 9:30 AM PDT

New Drug Boosts Bone Growth in Children with Dwarfism

WRITTEN BY: Annie Lennon

A Phase III global clinical trial by the Murdoch Children’s Research Institute (MCRI) has found that a new drug, known as vosoritide, is able to increase bone growth in children with achondroplasia, the most common type of dwarfism. 

A genetic bone disorder, achondroplasia, is known to affect around 250,000 people globally or approximately 1 in every 25,000 children. The condition is caused by overactivity of the FGFR3 protein, which reduces bone growth in children’s limbs, spine, and the base of the skull. Rather than growing 6-7 cm per year, children with the condition grow an average of 4cm per year. Current treatments for the condition, which include surgery, only address symptoms of the disorder.

Vosoritide, on the other hand, directly targets the molecular cause of the disease. It works by blocking the protein’s activity, ultimately returning growth rates to normal. While previous trials by MCRI showed that the drug is safe in young people with dwarfism, the new trial shows that it is also able to increase bone growth over one year with daily injections. 

For the randomized, placebo-controlled trial, researchers enrolled 121 children aged between 5 and 18 in 24 hospitals across seven countries. All in all, the researchers found that the the 60 children who received daily injections of vosoritide grew an average of 1.57 cm more than children who received the placebo- bringing their growth rates more or less in line with peers who do not have the disorder. 

The researchers did note, however, that the drug did not significantly improve the proportions between their upper and lower bodies. Nevertheless, the children will be followed until they reach their final adult height to see whether the drug’s effects are long-lasting and whether they have a growth spurt during puberty- something that is unusual among children with achondroplasia. 

Nevertheless, BioMarin Pharmaceutical, the manufacturer of the drug and funder of the trial, has applied to the US Food and Drug Administration to license vosoritide as a treatment for achondroplasia. The company also applied to the European Medicines Agency, which has since approved their application. 

 

SOurces: MecialXpressEurekAlert

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
AUG 25, 2020
Immunology
Targeting Checkpoint Molecule Could Mean Checkmate for Cancer
AUG 25, 2020
Targeting Checkpoint Molecule Could Mean Checkmate for Cancer
In a new study published in Cell, researchers have identified a metabolic enzyme that could have powerful tumor-killing ...
AUG 26, 2020
Cancer
NAP-6: A Potential Candidate for the Treatment of Breast Cancer
AUG 26, 2020
NAP-6: A Potential Candidate for the Treatment of Breast Cancer
The body is an amazing and complex system of pathways, all working together in harmony. However, cancer can quickly disr ...
AUG 25, 2020
Cannabis Sciences
Synthetic Cannabinoid Drug to Enter Human Trials
AUG 25, 2020
Synthetic Cannabinoid Drug to Enter Human Trials
In recent months, interest has been growing in the potential for cannabinoids- the compounds found in cannabis- to treat ...
OCT 01, 2020
Cancer
Understanding in vivo Metabolomics: C13 Isotope Studies
OCT 01, 2020
Understanding in vivo Metabolomics: C13 Isotope Studies
One key to understanding cancer metabolomics lies in the ability to accurately replicate the natural environment of the ...
OCT 12, 2020
Microbiology
Researchers May Have Found a Way to Cure Rotavirus Infections
OCT 12, 2020
Researchers May Have Found a Way to Cure Rotavirus Infections
Rotaviruses are very contagious. They are the most common cause of diarrhea in children and are estimated to cause about ...
OCT 13, 2020
Drug Discovery & Development
Uses of Tandem Mass Spectrometry (TMS)
OCT 13, 2020
Uses of Tandem Mass Spectrometry (TMS)
What is tandem mass spectrometry? A powerful analytical tool that is capable of characterizing complex mixtures in drug ...
Loading Comments...